Previous close | 7.9000 |
Open | 4.2000 |
Bid | 4.1000 |
Ask | 4.8000 |
Strike | 370.00 |
Expiry date | 2024-10-18 |
Day's range | 4.2000 - 4.2000 |
Contract range | N/A |
Volume | |
Open interest | 4 |
Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.